Experience

• 

  Ey

  Aug 2022 - now

  Senior analyst

  M&A Strategy with focus on Life Sciences:1. Target Scan– Lead strategic initiatives for pharma companies, driving investment opportunities to expand pipelines, acquire new technologies, access fresh markets, and boost market share via M&As. Develop customized target-scoring frameworks by analyzing complex life science data such as epidemiology, drug trials, patent expiry, MoAs, RoAs and various life science technologies. Proficient in utilizing industry-specific databases like Citeline (BMT, Pharmaprojects, Trial Trove, Datamonitor), EvaluatePharma, Clarivate, and IQVIA for informed decision-making and ensure project success.– Evaluate strategic fit of target companies for the acquirer by analyzing company financials, partnerships, and funding along with qualitative analysis of annual and quarterly filings, investor reports, and the company's future plans requiring proficiency in industry-agnostic databases including CapIQ, Pitchbook, Refinitiv, EMIS, and D&B2. White space analysis-Life Science (Identifying lucrative segments for investments):– Lead projects involving white space analysis for several big pharma companies– Analyze funding data from big pharma companies, CVC arms of big pharma companies, and PEVC firms to recognize therapeutic areas, indications, technologies, and MoAs receiving the most substantial funding– Analyze the current product developments in various segments under consideration to identify market traction– Conduct market sizing of indications by analyzing epidemiology data (prevalence and incidence of indications) Show less